Science and politics of heroin prescription

The Lancet

Volumn 375, Issue 9729, 2010, Pages 1849-1850

  Kerr, Thomas ^a,b   Montaner, Julio SG ^b,c   Wood, Evan ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE;

ARTICLE; BELGIUM; CLINICAL TRIAL; COCHRANE LIBRARY; CRIMINAL BEHAVIOR; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FRANCE; GERMANY; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEROIN DEPENDENCE; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH; PATIENT COMPLIANCE; POLITICAL SYSTEM; PRESCRIPTION; PRIORITY JOURNAL; SOCIAL STATUS; SPAIN; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

EID: 77952793421     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60544-2     Document Type: Note

References (15)

1. Sneader W. The discovery of heroin. Lancet 352 (1998) 1697-1699
2. Fischer B., Rehm J., Kirst M., et al. Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health 12 (2002) 228-234
3. Oviedo-Joekes E., Brissette S., Marsh D.C., et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 361 (2009) 777-786
4. Mattick R.P., Breen C., Kimber J., and Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 3 (2009) CD002209.
5. Haasen C., Verthein U., Degkwitz P., Berger J., Krausz M., and Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry 191 (2007) 55-62
6. Ferri M., Davoli M., and Percucci C.A. Heroin maintenance for chronic heroin dependents. Cochrane Database Syst Rev 3 (2003) CD003410.
7. March J.C., Oviedo-Joekes E., Perea-Milla E., Carrasco F., and the PEPSA team. Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat 31 (2006) 203-211
8. Strang J., Metrebian N., Lintzeris N., et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet 375 (2010) 1885-1895
9. Berridge V. Heroin prescription and history. N Engl J Med 361 (2009) 820-821
10. Wodak A., Ritter A.J., and Watson C.R.R. Separating politics and scientific research on heroin prescription. Med J Aust 176 (2002) 449
11. Fischer B., Oviedo-Joekes E., Blanken P., et al. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health 84 (2007) 552-562
12. Gartry C.C., Oviedo-Joekes E., Laliberté N., and Schechter M.T. NAOMI: the trials and tribulations of implementing a heroin assisted treatment study in North America. Harm Reduct J 6 (2009) 2
13. Kahan M., Arnold K., Baker R., et al. The NAOMI trial-a critical appraisal (Nov 20, 2008). http://www.addictiontreatmentcanada.blogspot.com (accessed March 10, 2010).
14. Schechter M. Supervised injections help heroin addicts who can't use methadone. The Province (Vancouver) (May 26, 2008). http://www2.canada.com/components/print.aspx?id=2eb962a0-f883-4a99-b05e- 63ef74e60648&sponsor (accessed March 11, 2010).
15. Oviedo-Joekes E., Marsh D., and Schetcher M. Author's reply. N Engl J Med 361 (2009) 2194